Resistance of primary cells to transformation by oncogenic Ras has been att
ributed to the induction of replicative growth arrest(1-3). This irreversib
le 'fail-safe mechanism' resembles senescence and requires induction by Ras
of p19(ARF) and p53 (refs 3-5). Mutation of either p19ARF or p53 alleviate
s Ras-induced senescence and facilitates oncogenic transformation by Ras(3,
6,7). Here we report that, whereas Rb and p107 are each dispensable for Ras
-induced replicative arrest, simultaneous ablation of both genes disrupts R
as-induced senescence and results in unrestrained proliferation. This occur
s despite activation by Ras of the p19(ARF)/p53 pathway, identifying pRb an
d p107 as essential mediators of Ras-induced antiproliferative p19ARF/p53 s
ignalling. Unexpectedly, in contrast to p19ARF or p53 deficiency, loss of R
b/p107 function does not result in oncogenic transformation by Ras, as Ras-
expressing Rb-/-/p107(-/-) fibroblasts fail to grow anchorage-independently
in vitro and are not tumorigenic in vivo. These results demonstrate that i
n the absence of both Rb and p107 cells are resistant to p19(ARF)/p53-depen
dent protection against Ras-induced proliferation, and uncouple escape from
Ras-induced premature senescence from oncogenic transformation.